Esophageal Neoplasms

"Esophageal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the ESOPHAGUS.

Descriptor ID	D004938
MeSH Number(s)	C04.588.274.476.205 C04.588.443.353 C06.301.371.205 C06.405.117.430 C06.405.249.205
Concept/Terms	Esophageal Neoplasms Esophageal Neoplasms Esophageal Neoplasm Neoplasm, Esophageal Esophagus Neoplasm Esophagus Neoplasms Neoplasm, Esophagus Neoplasms, Esophagus Neoplasms, Esophageal Cancer of Esophagus Cancer of Esophagus Cancer of the Esophagus Esophagus Cancer Cancer, Esophagus Cancers, Esophagus Esophagus Cancers Esophageal Cancer Cancer, Esophageal Cancers, Esophageal Esophageal Cancers

Below are MeSH descriptors whose meaning is more general than "Esophageal Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Gastrointestinal Neoplasms [C04.588.274.476]
Esophageal Neoplasms [C04.588.274.476.205]
Head and Neck Neoplasms [C04.588.443]
Esophageal Neoplasms [C04.588.443.353]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Gastrointestinal Neoplasms [C06.301.371]
Esophageal Neoplasms [C06.301.371.205]
Gastrointestinal Diseases [C06.405]
Esophageal Diseases [C06.405.117]
Esophageal Neoplasms [C06.405.117.430]
Gastrointestinal Neoplasms [C06.405.249]
Esophageal Neoplasms [C06.405.249.205]

Below are MeSH descriptors whose meaning is more specific than "Esophageal Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Esophageal Neoplasms" by people in this website by year, and whether "Esophageal Neoplasms" was a major or minor topic of these publications.

Bar chart showing 170 publications over 29 distinct years, with a maximum of 14 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	1	1	2
1998	3	0	3
1999	4	3	7
2000	2	1	3
2001	5	0	5
2002	6	2	8
2003	4	0	4
2004	1	1	2
2005	5	0	5
2006	6	2	8
2007	7	0	7
2008	11	3	14
2009	6	3	9
2010	6	4	10
2011	9	0	9
2012	6	1	7
2013	1	0	1
2014	6	0	6
2015	7	0	7
2016	8	0	8
2017	9	2	11
2018	4	0	4
2019	5	0	5
2020	9	0	9
2021	4	0	4
2022	3	0	3
2023	5	0	5
2024	2	0	2

Below are the most recent publications written about "Esophageal Neoplasms" by people in Profiles.

Su SH, Mitani Y, Li T, Sachdeva U, Flashner S, Klein-Szanto A, Dunbar KJ, Abrams J, Nakagawa H, Gabre J. Lactate Suppresses Growth of Esophageal Adenocarcinoma Patient-Derived Organoids through Alterations in Tumor NADH/NAD+ Redox State. Biomolecules. 2024 09 22; 14(9).

View in: PubMed
Flashner S, Shimonosono M, Tomita Y, Matsuura N, Ohashi S, Muto M, Klein-Szanto AJ, Alan Diehl J, Chen CH, Mochly-Rosen D, Weinberg KI, Nakagawa H. ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Carcinogenesis. 2024 02 12; 45(1-2):95-106.

View in: PubMed
Efe G, Dunbar KJ, Sugiura K, Cunningham K, Carcamo S, Karaiskos S, Tang Q, Cruz-Acu?a R, Resnick-Silverman L, Peura J, Lu C, Hasson D, Klein-Szanto AJ, Taylor AM, Manfredi JJ, Prives C, Rustgi AK. p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression. Cancer Discov. 2023 12 12; 13(12):2632-2651.

View in: PubMed
Dunbar KJ, Karakasheva TA, Tang Q, Efe G, Lin EW, Harris M, Sahu V, Sachdeva UM, Hu J, Klein-Szanto AJ, Henick B, Diehl JA, Nakagawa H, Rustgi AK. Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma. Mol Cancer Res. 2023 07 05; 21(7):741-752.

View in: PubMed
Kabir MF, Jackson JL, Fuller AD, Gathuka L, Karami AL, Conde DG, Klochkova A, Mu A, Cai KQ, Klein-Szanto AJ, Muir AB, Whelan KA. Diclofenac exhibits cytotoxic activity associated with metabolic alterations and p53 induction in ESCC cell lines and decreases ESCC tumor burden in vivo. Carcinogenesis. 2023 05 26; 44(2):182-195.

View in: PubMed
Fong LY, Huebner K, Jing R, Smalley KJ, Brydges CR, Fiehn O, Farber JL, Croce CM. Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in?vivo. Proc Natl Acad Sci U S A. 2023 05 16; 120(20):e2220334120.

View in: PubMed
Till BM, Grenda TR, Okusanya OT, Evans Iii NR. Robotic Minimally Invasive Esophagectomy. Thorac Surg Clin. 2023 Feb; 33(1):81-88.

View in: PubMed
Flashner S, Martin C, Matsuura N, Shimonosono M, Tomita Y, Morimoto M, Okolo O, Yu VX, Parikh AS, Klein-Szanto AJP, Yan K, Gabre JT, Lu C, Momen-Heravi F, Rustgi AK, Nakagawa H. Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids. J Vis Exp. 2022 12 23; (190).

View in: PubMed
Malla M, Fuqua J, Mukherjee S, Goldberg RM. Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus. Curr Treat Options Oncol. 2022 12; 23(12):1748-1760.

View in: PubMed
Till BM, Mandel J, Unal E, Juckett L, Grenda T, Okusanya O, Palazzo F, Chojnacki K, Evans NR. Cessation of Routine Jejunostomy Tube Placement at Time of Minimally Invasive Ivor Lewis Esophagectomy and Impact on Body Mass Index. Semin Thorac Cardiovasc Surg. 2024; 36(1):112-119.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement